Evaluation of Various Static and Dynamic Modeling Methods to Predict Clinical CYP3A Induction Using In Vitro CYP3A4 mRNA Induction Data

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|95|2|179-188

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.95, Iss.2, 2014-02, pp. : 179-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 189-198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 510-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 475-482

John Wiley & Sons Inc

Access to resources Recommend Favorite

In Vitro Prediction of Clinical Drug Interactions With CYP3A Substrates: We Are Not There Yet

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 133-135

John Wiley & Sons Inc

Access to resources Recommend Favorite

PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 6, 2012-06 ,pp. : 1044-1052

John Wiley & Sons Inc

Access to resources Recommend Favorite